Published on in Vol 9, No 8 (2020): August

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/16198, first published .
A Novel HIV-1 RNA Testing Intervention to Detect Acute and Prevalent HIV Infection in Young Adults and Reduce HIV Transmission in Kenya: Protocol for a Randomized Controlled Trial

A Novel HIV-1 RNA Testing Intervention to Detect Acute and Prevalent HIV Infection in Young Adults and Reduce HIV Transmission in Kenya: Protocol for a Randomized Controlled Trial

A Novel HIV-1 RNA Testing Intervention to Detect Acute and Prevalent HIV Infection in Young Adults and Reduce HIV Transmission in Kenya: Protocol for a Randomized Controlled Trial

Susan M Graham   1, 2, 3 , MD, MPH, PhD ;   Clara Agutu   4 , MBChB, MPH, MSc ;   Elise van der Elst   4 , PhD ;   Amin S Hassan   4 , MSc, PhD ;   Evanson Gichuru   4 , BSc ;   Peter M Mugo   4 , BPharm, MSc, PhD ;   Carey Farquhar   1, 2, 3 , MD, MPH ;   Joseph B Babigumira   1, 5 , MBChB, MS, PhD ;   Steven M Goodreau   3, 6 , MA, PhD ;   Deven T Hamilton   7 , MPH, PhD ;   Thumbi Ndung'u   8, 9, 10, 11 , PhD ;   Martin Sirengo   12 , MBChB ;   Wairimu Chege   13 , MD, MPH ;   Eduard J Sanders   4, 14 , MD, MPH, PhD

1 Department of Global Health, University of Washington, Seattle, WA, United States

2 Department of Medicine, University of Washington, Seattle, WA, United States

3 Department of Epidemiology, University of Washington, Seattle, WA, United States

4 Kenya Medical Research Institute - Wellcome Trust Research Programme, Kilifi, Kenya

5 Department of Pharmacy, University of Washington, Seattle, WA, United States

6 Department of Anthropology, University of Washington, Seattle, WA, United States

7 Center for Studies in Demography and Ecology, University of Washington, Seattle, WA, United States

8 Africa Health Research Institute, Durban, South Africa

9 HIV Pathogenesis Programme, Doris Duke Medical Research Institute, University of KwaZulu-Natal, Durban, South Africa

10 Max Planck Institute for Infection Biology, Berlin, Germany

11 Division of Infection and Immunity, University College London, London, United Kingdom

12 Department of Health Infrastructure Management, Ministry of Health, Nairobi, Kenya

13 Division of AIDS, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Rockville, MD, United States

14 University of Oxford, Headington, United Kingdom

Corresponding Author:

  • Susan M Graham, MD, MPH, PhD
  • Department of Global Health
  • University of Washington
  • Box 359909
  • 325 Ninth Avenue
  • Seattle, WA, 98104
  • United States
  • Phone: 1 2063510414
  • Email: grahamsm@uw.edu